Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location

Schizophrenia and Schizoaffective Disorders Clinical Trials

A listing of Schizophrenia and Schizoaffective Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (67) clinical trials

The purpose of the study is to determine how to best measure learning and memory in individuals who have a psychiatric illness. This study will take about 10 hours to complete (3 to 5 study visits). There will be an interview, questionnaires, and completion of tasks on a computer. $50.00 ...

Phase N/A

Research has shown that genes can make some people more likely than others to develop Schizophrenia or Bipolar disorder. The goal of our study is to identify these genes.

Phase N/A

Research has shown that genes can make some people more likely to develop Obsessive Compulsive Disorder and Related Disorders (Hoarding Disorder, Body Dysmorphic Disorder,Hair Pulling Disorder/Trichotillomania and Skin Picking Disorder/ Excoriation Disorder). Some of the goals of our study is to identify these genes.

Phase N/A

Outpatient study for an investigational medication for schizophrenia. Inclusionary Criteria: Males and females Between the ages of 18-70 Schizophrenia or Schizoaffective disorder Length of Study approx 2 month Total number of outpatient visits: 7

Phase N/A

An 8 week, placebo-controlled, double-blind, randomized, fixed-dose efficacy and safety study of asenapine in adolescent subjects with schizophrenia. Patient Inclustion Criteria: The subject is aged between 10 and 17 years, inclusive. The subject suffers from schizophrenia.

Phase

A randomized, double-blind, placebo-controlled, parallel-26 week, phase 3 study of 2 doses of an alpha-nicotinic acetylcholine receptor agonist (EVP-6124) or placebo as an adjunctive pro-cognitive treatment in schizophrenic subjects on chronic stable atypical antipsychotic therapy.

Phase
Phase N/A

Daniel Mamah, MD is conducting a research study to examine brain functional connectivity and network patterns in participants with schizophrenia or bipolar disorder. Participation includes 2 outpatient study visits that will last about 2 - 5 hours each. There will be an MRI scan and clinical assessment/interview. Possible risks and ...

Phase N/A

An adaptive, Phase IIB/III, double-blind, randomized, placebo-controlled, multi-center study of the safety and efficacy of study drug used for treatment of Schizophrenia in Adolescents

Phase N/A

The study will evaluate the antipsychotic efficacy of ITI-007 in a randomized, double-blind, parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with schizophrenia having an acute exacerbation of psychosis.

Phase